154 related articles for article (PubMed ID: 2698564)
1. [Anti-arrhythmia effects of calcium antagonists].
Gülker H; Ketteler T
Z Kardiol; 1989; 78 Suppl 5():49-54. PubMed ID: 2698564
[TBL] [Abstract][Full Text] [Related]
2. The effects of mibefradil, a novel calcium channel antagonist on ventricular arrhythmias induced by myocardial ischemia and programmed electrical stimulation.
Billman GE; Hamlin RL
J Pharmacol Exp Ther; 1996 Jun; 277(3):1517-26. PubMed ID: 8667218
[TBL] [Abstract][Full Text] [Related]
3. [Calcium channel antagonists and arrhythmias].
Takahashi N; Saikawa T
Clin Calcium; 2005 Oct; 15(10):1651-5. PubMed ID: 16199910
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of heart arrhythmias with calcium antagonists].
Bender F
Z Kardiol; 1984; 73 Suppl 2():101-5. PubMed ID: 6084911
[TBL] [Abstract][Full Text] [Related]
5. Verapamil in cardiac arrhythmias: an overview.
Vohra J
Clin Exp Pharmacol Physiol Suppl; 1982; 6():129-34. PubMed ID: 6749351
[TBL] [Abstract][Full Text] [Related]
6. Use of calcium antagonists for cardiac arrhythmias.
Singh BN; Nademanee K
Am J Cardiol; 1987 Jan; 59(3):153B-162B. PubMed ID: 2433930
[TBL] [Abstract][Full Text] [Related]
7. The antiarrhythmic and antifibrillatory effects of calcium antagonists.
Billman GE
J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S107-17. PubMed ID: 1724998
[TBL] [Abstract][Full Text] [Related]
8. Control of cardiac arrhythmias by calcium antagonism.
Nademanee K; Singh BN
Ann N Y Acad Sci; 1988; 522():536-52. PubMed ID: 3288060
[TBL] [Abstract][Full Text] [Related]
9. [Ischemic disorders of cardiac rhythm: effects of the autonomic nervous system on electrophysiologic findings and pharmacotherapy].
Gülker H; Thale J
Z Kardiol; 1986; 75 Suppl 5():15-34. PubMed ID: 3825228
[TBL] [Abstract][Full Text] [Related]
10. Use of calcium channel entry blockers in the treatment of cardiac arrhythmias.
Akhtar M; Tchou P; Jazayeri M
Circulation; 1989 Dec; 80(6 Suppl):IV31-9. PubMed ID: 2688983
[TBL] [Abstract][Full Text] [Related]
11. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)].
Nakaya H
Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455
[TBL] [Abstract][Full Text] [Related]
12. [Calcium antagonists in treatment of ventricular tachycardia].
Melichercik J; Schöls W; Beyer T; Schweizer M; Brachmann J; Kübler W
Z Kardiol; 1996 May; 85(5):319-25. PubMed ID: 8711944
[TBL] [Abstract][Full Text] [Related]
13. Antiarrhythmic and anti-ischemic properties of calcium-channel antagonists.
Apostolakos MJ; Varon ME
New Horiz; 1996 Feb; 4(1):45-57. PubMed ID: 8689275
[TBL] [Abstract][Full Text] [Related]
14. [Exogenous adenosine as an anti-arrhythmia agent].
Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
[TBL] [Abstract][Full Text] [Related]
15. Calcium antagonists. Clinical use in the treatment of arrhythmias.
Singh BN; Nademanee K; Baky SH
Drugs; 1983 Feb; 25(2):125-53. PubMed ID: 6339197
[TBL] [Abstract][Full Text] [Related]
16. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
Blagova OV; Nedostup AV
Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214
[TBL] [Abstract][Full Text] [Related]
17. Calcium antagonists and acute myocardial ischemia: comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds.
Gülker H; Haverkamp W; Hindricks G; Bender F
Cardiovasc Drugs Ther; 1987 Dec; 1(4):367-76. PubMed ID: 3154673
[TBL] [Abstract][Full Text] [Related]
18. [Effects of injectable calcium blockers on cardiac function and relaxation in left ventricular hypertrophy].
Colle JP; Ohayon J; Besse P
Arch Mal Coeur Vaiss; 1985 Nov; 78(12):1843-51. PubMed ID: 2935109
[TBL] [Abstract][Full Text] [Related]
19. The comparative effects of diltiazem and verapamil on atrioventricular conduction and atrioventricular reentry tachycardia.
Rowland E; McKenna WJ; Gülker H; Krikler DM
Circ Res; 1983 Feb; 52(2 Pt 2):I163-8. PubMed ID: 6831649
[TBL] [Abstract][Full Text] [Related]
20. Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ.
Bui-Xuan B; Aupetit JF; Freysz M; Faucon G; Timour Q
Pharmacotherapy; 1997; 17(4):737-45. PubMed ID: 9250551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
